6505--Ranibizumab (Byooviz) Vials Base Year Ordering Period - 12/23/23 to 12/22/24
Award Notice Posted
- Solicitation number
- 36E79723R0018
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Awarded
- to Biogen U.s. Corporation
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36E79724D0002 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs awarded a contract to Biogen U.S. Corporation on October 23, 2023 for the provision of 1,139,206.34 units of ranibizumab (Byooviz) vials under solicitation number 36E79723R0018. The base year ordering period for the $11,392,063.40 contract is from December 23, 2023 to December 22, 2024 to support the medical needs of the agency. The contracting office is located in Hines, Illinois.
Notice text
Awarded contract 36E79724D0002 to Biogen U.S. Corporation for 11392063.40000000 on 2023-10-23.
Files
| File | Type | Posted |
|---|---|---|
| 36E79724D0002.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| 6505--Ranibizumab (Lucentis) Syringes Base Year Ordering Period - 12/23/23 to 12/22/24 | Award Notice | |
| 6505--Ranibizumab | Solicitation | |
| 6505--Ranibizumab | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity